Investors expect limited growth for Jiangsu Nhwa Pharmaceuti...
Investors expect limited growth for Jiangsu Nhwa Pharmaceutical, reflected in a low P/E ratio. The inferior earnings outlook compared to the market justifies this lowered P/E. Dismal earnings could further hinder the share price increase.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000233719bee4b9bc.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment